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Abstract
Background: Because H2O2 is generated by various oxidase-catalyzed reactions, a highly sensitive determination method of
H2O2 is applicable to measurements of low levels of various oxidases and their substrates such as glucose, lactate,
glutamate, urate, xanthine, choline, cholesterol and NADPH. We propose herein a new, highly sensitive method for the
measurement of H2O2 and glucose using fluorescence correlation spectroscopy (FCS).
Methodology/Principal Findings: FCS has the advantage of allowing us to determine the number of fluorescent molecules.
FCS measures the fluctuations in fluorescence intensity caused by fluorescent probe movement in a small light cavity with a
defined volume generated by confocal illumination. We thus developed a highly sensitive determination system of H2O2 by
FCS, where horseradish peroxidase (HRP) catalyzes the formation of a covalent bond between fluorescent molecules and
proteins in the presence of H2O2. Our developed system gave a linear calibration curve for H2O2 in the range of 28 to
300 nM with the detection limit of 8 nM. In addition, by coupling with glucose oxidase (GOD)-catalyzed reaction, the
method allows to measure glucose in the range of 80 nM to 1.5 mM with detection limit of 24 nM. The method was
applicable to the assay of glucose in blood plasma. The mean concentration of glucose in normal human blood plasma was
determined to be 4.9 mM.
Conclusions/Significance: In comparison with commercial available methods, the detection limit and the minimum value of
determination for glucose are at least 2 orders of magnitude more sensitive in our system. Such a highly sensitive method
leads the fact that only a very small amount of plasma (20 nL) is needed for the determination of glucose concentration in
blood plasma.
Citation: Watabe S, Sakamoto Y, Morikawa M, Okada R, Miura T, et al. (2011) Highly Sensitive Determination of Hydrogen Peroxide and Glucose by Fluorescence
Correlation Spectroscopy. PLoS ONE 6(8): e22955. doi:10.1371/journal.pone.0022955
Editor: Jianghong Rao, Stanford, United States of America
Received March 29, 2011; Accepted July 1, 2011; Published August 5, 2011
Copyright:  2011 Watabe et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was partly funded by a research grant of the ‘‘New Regional Consortium Research and Development Project’’ from the Ministry of Economy,
Trade, and Industry of Japan and the Hokkaido Bureau of Economy, Trade, and Industry, and a research grant of the ‘‘Knowledge Cluster Initiative (2009)’’ from the
Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish,
or preparation of the manuscript. Satoshi Watabe is an employee of BL Co. Ltd. and contributed to all aspects of the study.
Competing Interests: Satoshi Watabe is an employee of BL Co. Ltd. There are no patents, products in development or marketed products to declare. This does
not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials.
* E-mail: eito@kph.bunri-u.ac.jp
Introduction
A simple and highly sensitive method for the determination of
hydrogen peroxide (H2O2) has broad analytical applications. It is
applicable for the measurements of very low levels of H2O2 in
foods, consumer products and environmental waters such as
rainwater [1]–[3]. H2O2 is also present in a variety of biological
systems and induces diverse biological effects [4]. For instance,
H2O2 regulates various cellular processes as a signaling molecule
whereas its cytotoxic effects are associated with the initiation and
progression of many diseases [5]. Because these effects are
dependent on the cellular level of H2O2, the measurement of
low concentration of H2O2 is important for the study on the
association of H2O2 with diseases. In addition, because H2O2 is
generated by an oxidase-mediated reaction, its determination is a
basis for the assay of various oxidases and their substrates such as
glucose, lactate, glutamate, urate, xanthine, choline, cholesterol
and NADPH [1]–[3], [6].
Many methods are now available for the assay of H2O2 in
biological samples. They are spectrophotometry, fluorometry,
chemiluminescence and electrochemistry [1]–[][3]. Among these
methods, horseradish peroxidase (HRP)-catalyzed color and
fluorescence reactions have been widely used for the assay of
H2O2 because of their simplicity and high selectivity [1], [2], [7]–
[9]. Due to its low background fluorescence, HRP-catalyzed
oxidation of 10-acetyl-3,7-dihidroxyphenoxazine (Amplex
TM Red)
with H2O2, which forms a highly fluorescent resorfin (lex=
563 nm; lem=587 nm), has been extensively utilized for the
assay of low concentration of H2O2 in biological samples.
However, its detection limit for H2O2 is 50 nM [1], [10].
Recently, fluorescence correlation spectroscopy (FCS) has been
applied to characterize and determine fluorescent components in
aqueous solution at nanomolar concentrations [11], [12]. FCS
measures the fluctuation in fluorescence intensity caused by
diffusion of fluorescent components through a small light cavity
with a confocal detection volume (0.25 fL), and analysis of the
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concentration of fluorescent components in sample solution.
When a fluorescent probe of low-molecular weight binds to
protein in sample solution, slow-diffusing component (protein
labeled with fluorescent probes) increases with the decrease in fast-
diffusing component (fluorescent probe), which affects the
fluorescence autocorrelation curve in FCS. The fluorescence
autocorrelation curve is obtained after the fluctuations are
recorded as a function of time and statistically analyzed by
autocorrelation analysis. The average residence time (t) and the
absolute numbers of slow- and fast-diffusing components in the
small volume can be deduced by the fluorescence autocorrelation
function calculated from the fluorescence autocorrelation curve.
In order to develop a highly sensitive method for the assay of
H2O2 by FCS, we used tyramide labeled with tetramethyl
rhodamine (tyramide-TMR) as a fluorescent probe and bovine
serum albumin (BSA) as a protein. Tyramide labeled with
fluorescent probes have been utilized as reporter fluorescent
substrate for HRP-catalyzed deposition (CARD) that is signal
amplification technique in immunoassay and in situ hybridization
of nucleic acids [13,14]. Similarly to tyramine and tyrosine [9],
[15], [16], the tyramide gives 2,29-dihydroxydiphenyl derivatives
via tyramide radical, in the HRP-catalyzed oxidation with H2O2
when it is present at high concentrations. However, when applied
at lower concentrations in the presence of BSA, tyramide radical
binds to an electron-rich moieties of BSA such as a tyrosine
residue, to give TMR-labeled BSA [14], as shown in Figure 1.
Under the optimized conditions, TMR-labeled BSA (fraction of
slow-diffusing component) measured by FCS was found to be
proportional to H2O2 concentration of sample solution from
28 nM to 300 nM with a detection limit of 8 nM (S/N=3). By
coupling with glucose oxidase (GOD)-mediated reaction, the
present method was applicable to selective assay of glucose
(Figure 1) with a detection limit of 24 nM, which enabled to assay
glucose in human plasma with only a very small amount of plasma
(20 nL).
Methods
Reaction solution for H2O2 determination
The reaction solution consisted of 0.001% P-10, 10 nM
tyramide-TMR (Perkin Elmer, Waltham, MA, USA), 2 mg/mL
BSA, and 3 U/mL HRP (Roche, Basel, Switzerland) in 100 mM
Tris buffer (pH 7.5). Here, P-10 is a detergent for the suppression
of binding between tyramide-TMR and reaction tubes. The P-10
was kindly provided by Tauns, Numazu, Japan. To the reaction
solution of 480 mL, 20 mL of various concentrations of H2O2
solution (0, 0.2, 0.25, 0.5, 2.0, 2.5, 5.0, 7.5, and 12.5 mM) was
added and incubated in a chambered coverslip (Lab-Tek 155411;
Nalge Nunc International, Roskilde, Denmark) of FCS at room
temperature for 20 min. For each concentration of the H2O2
solution, the measurements by FCS were performed 3 times.
Reaction solution for glucose determination
The reaction solution consisted of 0.001% P-10, 10 nM
tyramide-TMR, 2 mg/mL BSA, 5 U/mL HRP, and 5 U/mL
GOD (Roche) in 100 mM Tris buffer (pH 7.5). To the reaction
solution (480 mL), 20 mL of various concentrations of glucose
solution (0, 0.50, 0.75, 1.25, 2.50, 10.0, 20.0, 25.0, 30.0, 37.5 and
50.0 mM) was added and incubated in a chambered coverslip of
FCS at room temperature for 30 min. For each concentration of
the glucose solution, the measurements by FCS were performed 3
times.
Determination of glucose in human blood plasma
The reaction solution was the same as that for glucose as
described above. Human blood plasma was purchased from
George King Bio-Medical (Cat No. 0020; Overland Park, KS,
USA). The plasma solutions were prepared by dilution with
distilled water by a factor of 200, 400, 500, 1000, 1600 and 2000.
The reaction solution (480 mL) and the diluted plasma solution
(20 mL) were mixed and incubated in a chambered coverslip of
FCS at room temperature for 30 min. For each concentration of
the plasma solution, the measurements by FCS were performed 3
times.
FCS measurement
The FCS used here was NovousGene Compact FCS (NG1532,
Hamamatsu Photonics, Hamamatsu, Japan), which consisted of an
LD-excitation solid-state laser (maximum power=1 mW) and a
water immersion objective (406, NA=1.15; Olympus, Tokyo,
Japan). The excitation wavelength was 532 nm, and emissions
were detected at 565 nm. The confocal pinhole diameter was
adjusted to 25 mm. The sample volume was 500 mL. The diffusion
time (tfree) of tyramide-TMR was obtained from the experiments
with 0 mMH 2O2 solution or 0 mM glucose solution, and this
diffusion time was fixed throughout the FCS measurements. The
diffusion time (tbound) of tyramide-TMR-BSA was obtained from
the experiments with 12.5 mMH 2O2 solution or 50.0 mM glucose
solution, and this time was also fixed throughout the FCS
measurements. For experiments with human plasma, both the
diffusion time (tfree) of tyramide-TMR and the diffusion time
(tbound) of tyramide-TMR-BSA were set to be the same as the
values for glucose solution. The FCS data were analyzed by
software equipped with the FCS (Hamamatsu Photonics).
Figure 1. Scheme of the enzymatic reaction. This scheme shows
binding between tyramide labeled with tetramethyl rhodamine (TMR)
and proteins by peroxidase and H2O2. Because the H2O2 concentrations
correspond to those of the proteins labeled with tyramide-TMR, we can
determine the concentrations of H2O2 by FCS. Further, because H2O2 is
produced by the reaction between glucose and glucose oxidase, we
can determine the concentrations of H2O2 and thus deduce the
concentrations of glucose.
doi:10.1371/journal.pone.0022955.g001
Glucose Determination by FCS
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Amplex
TM Red
As a commercial available method for comparison with the
present method, we used the Amplex
TM Red glucose/glucose
oxidase assay kit (A22189; Molecular Probes, Eugene, OR, USA)
for measurements of H2O2 and glucose. The measurements were
performed according to the manufacturer’s manual. We measured
the absorbance of 571 nm using a multimode microplate reader
(SpectraMax M5TB, Molecular Devices, Sunnyvale, CA, USA).
For each concentration of H2O2 solution or glucose solution, the
measurements with Amplex
TM Red were performed 3 times.
Detection limit and minimum value of determination
All the experimental data were obtained by subtracting the
mean value of blank signals from each of the corresponding
measured data. The limit of detection was obtained by
36(standard deviation of blank signals)/(slope of a regression line
for experimental data), and the minimum value of determination
was obtained by 106(standard deviation of blank signals)/(slope of
a regression line for experimental data).
Results
Determination of H2O2 concentrations
In the FCS experiments, when the H2O2 concentrations were
increased, the existence ratio for tyramide-TMR decreased while
that for tyramide-TMR-BSA increased. The former existence
ratio was referred to as F1, and the latter was F2. The FCS curve
proved that our FCS measurements were successful (Figure 2A).
As shown in Figure 2B, a linear relation between H2O2
concentration and F2 was obtained in the range of 28–300 nM
H2O2 with the detection limit of 8 nM. In a commercial available
method using Amplex
TM Red, we found that the detection limit
was 19 nM and that the range of determination was 65 nM–1 mM
(Figure 2C). That is, the detection limit and the minimum value of
determination for H2O2 in our system were slightly more sensitive
than by the commercial available method.
Determination of glucose concentrations
The determination of b-D-glucose is important in the area of
industrial quality control and processing applications as well as in
clinical diagnosis and treatment of diabetes [17]–[19]. Although
various methods for the determination of glucose have been
reported, enzymatic ones using GOD have been widely used due
to their simplicity and selectivity. Therefore, we attempted to
develop a highly sensitive method for the determination of glucose
by coupling our FCS method with GOD-catalyzed oxidation of
glucose (Figure 1). Under the optimized conditions, a linear
relation between glucose concentrations and F2 (i.e. existence ratio
for tyramide-TMR-BSA) was obtained in the range of 80 nM–
1.5 mM glucose with the detection limit of 24 nM as shown in
Figure 3A. In contrast, a commercial available method using
Amplex
TM Red showed a limit of detection of 2 mM and a range
of determination of 6 mM–50 mM (Figure 3B). That is, the
detection limit and the minimum value of determination for
glucose in our system were at least 2 orders of magnitude more
sensitive than in the commercial available method.
Determination of glucose concentrations in human
blood plasma
The relation between dilution factor of plasma and F2 is shown
in Figure 4. The limit of detection was obtained by use of the
diluted plasma of 0.2610
24. The range of determination was
Figure 2. Determination of H2O2 concentration. A. FCS curve
proves that our FCS measurements are successful for the detection of
0.2 mMH 2O2. B. Calibration curve by an FCS method. F2 indicates the
existence ratio for tyramide-TMR-BSA. The SD values are too small to set
the error bars in this figure. For example, when the H2O2 concentration
was 0.008 mM, the average value of F2 was 1.2% and the SD value was
1.0%. When the H2O2 concentration was 0.2 mM, the average value of
F2 was 29.1% and the SD value was 2.8%. C. Calibration curve by the
Amplex
TM Red method. The measurements by FCS and Amplex
TM Red
were performed 3 times each.
doi:10.1371/journal.pone.0022955.g002
Glucose Determination by FCS
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24 and that of 2.0610
24.
We thus applied the F2 values obtained from the diluted plasma of
0.4610
24, 1.0610
24 and 2.0610
24 to the calibration curve of
Figure 3A, and calculated the glucose concentrations by taking
account of dilution. As a result, the glucose concentrations in
human blood plasma were estimated to be 4.0 mM, 5.4 mM and
5.4 mM for the diluted plasma of 0.4610
24, 1.0610
24 and
2.0610
24, respectively. The average value of 4.9 mM is in good
agreement with the data (3.9–6.1 mM) that are presented in a
textbook of physiology [20]. Further, we asked a clinical
laboratory examination company (Shikoku Chuken, Ayagawa,
Kagawa, Japan) to measure the glucose concentration of our
sample and obtained 4.6 mM, supporting that our data were
reasonable. However, it is noteworthy that our method needs only
20 nL plasma for this determination. That is, only about 40 nL is
needed as a blood sample. In contrast, when we used the
Amplex
TM Red method, the glucose concentrations were obtained
to be 67 mM and 158 mM for the diluted plasma of 0.5610
24
and that of 5.0610
24, respectively. The values seem incorrect (see
Discussion).
Discussion
A current priority is the development of simple and rapid
methods that facilitate reproducible determination of various
species at low concentrations [21]. In the present study, we applied
FCS to detect and determine H2O2 and glucose at low
concentrations. Our developed system using FCS is versatile
because of its use of a commercially available fluorescent probe,
but not radio isotopes or other special chemicals. We thus
succeeded in determining glucose concentrations by the detection
of H2O2 generated from the GOD-catalyzed oxidation of glucose.
The detection limit and the minimum value of determination for
glucose were found to be at least 2 orders of magnitude more
sensitive than with the commercial available method. We should
note that not only BSA (2 mg/mL=3.0610
28 mol/mL) but also
HRP (5 U/mL=3.6610
211 mol/mL) and GOD (5 U/mL=
1.6610
210 mol/mL) were included in the reaction solution with
tyramide-TMR for the FCS measurements. However, the reaction
involved in both HRP and GOD can be neglected because the
molar ratio of (HRP and GOD)/BSA was ,0.0065. That is, the
fluorescence signals detected by FCS were thought to mainly
originate from free tyramide-TMR and tyramide-TMR-labeled
BSA.
At present, Amplex
TM Red is widely used for the detection of H2O2
[10]. However, the use of Amplex
TM Red offered us the extraordinary
data of glucose concentration in human blood plasma (e.g. .tens of
mM). This fact might be caused due to the reaction between
Amplex
TM Red and some molecules in blood plasma. For example,
there seem to be some inhibition in the HRP reaction by reducing
agents like ascorbate and cysteine in human blood. We do not know
the exact reason but this inhibition is well canceled in our FCS
method. Therefore, our developed method is completely superior to
the measurement by use of Amplex
TM Red. Moreover, our method is
thought to be useful to detect the concentration of other molecules in
organisms if the corresponding oxidase is available.
We should note that we need only a small amount of blood (i.e.
tens of nano litter) to determine the glucose concentration in
Figure 3. Determination of glucose concentration. A. Calibration
curve by an FCS method. F2 indicates the existence ratio for tyramide-
TMR-BSA. The SD values are too small to set the error bars in this figure.
For example, when the glucose concentration was 1.0 mM, the average
value of F2 was 41.8% and the SD value was 1.3%. When the glucose
concentration was 1.5 mM, the average value of F2 was 61.4% and the
SD value was 2.4%. B. Calibration curve by the Amplex
TM Red method.
The measurements by FCS and Amplex
TM Red were performed 3 times
each.
doi:10.1371/journal.pone.0022955.g003
Figure 4. Determination of glucose concentration in human
blood plasma. The measurements by FCS were performed 3 times.
The F2 values obtained here were calibrated by Figure 3A, and then the
glucose concentrations were calculated by taking account of dilution.
doi:10.1371/journal.pone.0022955.g004
Glucose Determination by FCS
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method will offer the biopsy that reduces a burden to patients. For
example, when using alcohol oxidase, we will detect the blood
alcohol concentration. The use of ascorbate oxidase will detect the
ascorbate concentration in foods; the use of cholesterol oxidase will
detect the blood cholesterol concentration for medical checkup;
the use of choline oxidase will detect the blood choline
concentration for mental condition check; and the use of pyruvate
oxidase will detect the blood pyruvate concentration for freshness
check of preserved blood [1]–[3], [6]. The second one is that our
method will contribute to facilitate medical and biological
researches at a single-cell level. Because the contents in cells do
not prevent from determination of a target molecule in our FCS
method, the second advantage will be realized in the near future.
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